These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 23492856)

  • 1. Production of Ibuprofen Pellets Containing High Amount of Rate Retarding Eudragit RL Using PEG400 and Investigation of Their Physicomechanical Properties.
    Sadeghi F; Hijazi H; Garekani HA
    Iran J Basic Med Sci; 2011 Jul; 14(4):383-90. PubMed ID: 23492856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thermal treating as a tool to produce plastic pellets based on Eudragit RS PO and RL PO aimed for tableting.
    Abbaspour MR; Sadeghi F; Afrasiabi Garekani H
    Eur J Pharm Biopharm; 2007 Aug; 67(1):260-7. PubMed ID: 17337169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation and characterization of ibuprofen pellets based on Eudragit RS PO and RL PO or their combination.
    Abbaspour MR; Sadeghi F; Garekani HA
    Int J Pharm; 2005 Oct; 303(1-2):88-94. PubMed ID: 16153792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation and characterization and release properties of Eudragit RS based ibuprofen pellets prepared by extrusion spheronization: effect of binder type and concentration.
    Garekani HA; Nokhodchi A; Rayeni MA; Sadeghi F
    Drug Dev Ind Pharm; 2013 Aug; 39(8):1238-46. PubMed ID: 22873946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New co-processed MCC-based excipient for fast release of low solubility drugs from pellets prepared by extrusion-spheronization.
    Goyanes A; Martínez-Pacheco R
    Drug Dev Ind Pharm; 2015 Mar; 41(3):362-8. PubMed ID: 24279425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of the ratio of two acrylic polymers on the in vitro release kinetics of ketoprofen from pellets prepared by extrusion and spheronisation technique.
    Kibria G; Ul-Jalil R
    Pak J Pharm Sci; 2008 Apr; 21(2):92-7. PubMed ID: 18390436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and study of ibuprofen disintegrating sustained-release tablets comprising coated pellets.
    Abbaspour MR; Sadeghi F; Afrasiabi Garekani H
    Eur J Pharm Biopharm; 2008 Mar; 68(3):747-59. PubMed ID: 17977701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation and evaluation of sustained-release doxazosin mesylate pellets.
    Ha JM; Kim JY; Oh TO; Rhee YS; Chi SC; Kuk H; Park CW; Park ES
    Chem Pharm Bull (Tokyo); 2013; 61(4):371-8. PubMed ID: 23385960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The preparation by extrusion/spheronization and the properties of pellets containing drugs, microcrystalline cellulose and glyceryl monostearate.
    Chatchawalsaisin J; Podczeck F; Newton JM
    Eur J Pharm Sci; 2005 Jan; 24(1):35-48. PubMed ID: 15626576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and Characterization of Eudragit-RL-100-Based Aceclofenac Sustained-Release Matrix Pellets Prepared via Extrusion/Spheronization.
    Ibrahim MA; Alshora DH
    Polymers (Basel); 2021 Nov; 13(22):. PubMed ID: 34833333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of physicomechanical properties of films prepared from organic solutions and aqueous dispersion of Eudragit RL.
    Sadeghi F; Shahabi M; Afrasiabi H
    Daru; 2011; 19(2):100-6. PubMed ID: 22615646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Co-processed MCC-Eudragit® E excipients for extrusion-spheronization.
    Goyanes A; Souto C; Martínez-Pacheco R
    Eur J Pharm Biopharm; 2011 Nov; 79(3):658-63. PubMed ID: 21827853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and Optimization of a Floating Multiparticulate Drug Delivery System for Norfloxacin.
    Salve V; Mishra R; Nandgude T
    Turk J Pharm Sci; 2019 Sep; 16(3):326-334. PubMed ID: 32454731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of ethylcellulose and its pseudolatex (Surelease) in preparation of matrix pellets of theophylline using extrusion-spheronization.
    Garekani HA; Dolatabadi R; Akhgari A; Abbaspour MR; Sadeghi F
    Iran J Basic Med Sci; 2017 Jan; 20(1):9-16. PubMed ID: 28133518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Compression of controlled-release pellets produced by a hot-melt extrusion and spheronization process.
    Young CR; Dietzsch C; McGinity JW
    Pharm Dev Technol; 2005; 10(1):133-9. PubMed ID: 15776821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Moisture plasticization for enteric Eudragit® L30D-55-coated pellets prior to compression into tablets.
    Rujivipat S; Bodmeier R
    Eur J Pharm Biopharm; 2012 May; 81(1):223-9. PubMed ID: 22269937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Preparation and properties of sustained-release pellets of glycyrrhizin effective components].
    Chen LH; Feng Y; Xu DS; Li JS; Zhang L; Wang YH
    Zhongguo Zhong Yao Za Zhi; 2008 Mar; 33(5):509-13. PubMed ID: 18536370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The evaluation of formulations for the preparation of pellets with high drug loading by extrusion/spheronization.
    Podczeck F; Knight P
    Pharm Dev Technol; 2006; 11(3):263-74. PubMed ID: 16895837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation and evaluation of pellets using acacia and tragacanth by extrusion-spheronization.
    Akhgari A; Abbaspour MR; Pirmoradi S
    Daru; 2011; 19(6):417-23. PubMed ID: 23008687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Formulation of ranitidine pellets by extrusion-spheronization with little or no microcrystalline cellulose.
    Basit AW; Newton JM; Lacey LF
    Pharm Dev Technol; 1999; 4(4):499-505. PubMed ID: 10578503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.